Internal Medicine, Rheumatology · Bemidji, MN
NPI
1124043229
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1300 Anne St NW
Bemidji, MN, 56601
Phone (218) 333-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$243K
15,173 services
Medicare patients, 2024
260
Average age 71
Drug cost, 2024
$429K
3,034 prescriptions
Company payments, 2025
$1,500
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John D Kolstoe was code J0897 (injection, denosumab, 1 mg), 3,600 times for 56 patients. In total John D Kolstoe billed 15,173 services in 46 codes, and Medicare paid $243K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,600 | 56 | $20.08 | $72K |
| 99214 Office E&M - Established | Office | 227 | 155 | $88.23 | $20K |
| 99213 Office E&M - Established | Office | 112 | 89 | $62.40 | $6,989 |
| 96372 Injection Administration | Office | 106 | 68 | $10.02 | $1,062 |
| 99215 Office E&M - Established | Office | 75 | 49 | $113.17 | $8,488 |
| 96365 Intravenous Infusion, Hydration | Office | 32 | 17 | $44.26 | $1,416 |
| 99204 Office E&M - New | Office | 24 | 24 | $112.68 | $2,704 |
| 99406 Behavioral Health Services | Office | 20 | 13 | $13.92 | $278 |
| 36415 Venipuncture Blood Collection | Office | 19 | 14 | $8.65 | $164 |
| G0008 Administration of influenza virus vaccine | Office | 11 | 11 | $30.87 | $340 |
By year: 2022 $40K for 1,374 services; 2023 $169K for 9,983 services; 2024 $243K for 15,173 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 19 | 14 | $8.65 | $164 |
Medicare prescription drug claims, 2024
In 2024, the drug John D Kolstoe prescribed most often to Medicare patients was Fluticasone Propionate, with 353 prescriptions and refills. In total John D Kolstoe wrote 3,034 Medicare prescriptions that cost $429K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 353 | 508 | 132 | $4,917 |
| Ipratropium Bromide Generic | 347 | 396 | 130 | $10K |
| Tizanidine Hcl Generic | 329 | 528 | 120 | $3,349 |
| Prednisone Generic | 245 | 423 | 66 | $2,362 |
| Cyclobenzaprine Hcl Generic | 139 | 233 | 50 | $985 |
| Spironolactone Generic | 115 | 191 | 31 | $2,043 |
| Omeprazole Generic | 112 | 322 | 52 | $1,676 |
| Imipramine Hcl Generic | 100 | 126 | 27 | $1,504 |
| Gabapentin Generic | 94 | 121 | 26 | $1,047 |
| Tramadol Hcl Generic | 92 | 112 | 27 | $841 |
| Pregabalin Generic | 89 | 152 | 29 | $1,135 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 83 | 169 | 24 | $2,396 |
| Diflunisal Generic | 78 | 102 | 25 | $7,152 |
| Montelukast Sodium Generic | 70 | 201 | 31 | $1,640 |
| Hydroxychloroquine Sulfate Generic | 67 | 163 | 24 | $5,176 |
Brand drugs: - claims; generic drugs: 2,943 claims; opioid claims: 97.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John D Kolstoe $1,500 ($1,500 in general payments such as food, travel and fees) from 17 companies. The largest payer was Janssen Biotech, Inc. with $291.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 42 | $291 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $283 |
| Amgen Inc. AMGN | 16 | $244 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $225 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $106 |
| Fresenius Kabi USA, LLC | 4 | $87.73 |
| Lilly USA, LLC LLY | 2 | $50.66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35.57 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $25.7 |
| Bioventus LLC BVS | 1 | $23.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.